• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

肺北京诺卡菌感染与多发性硬化症患者使用阿仑单抗有关。

Pulmonary Nocardia beijingensis infection associated with the use of alemtuzumab in a patient with multiple sclerosis.

机构信息

Department of Pharmacy Practice, Lebanese American University, Beirut, Lebanon.

Department of Internal Medicine, UAB School of Medicine, Huntsville, AL, USA.

出版信息

Mult Scler. 2017 May;23(6):872-874. doi: 10.1177/1352458517694431. Epub 2017 Feb 1.

DOI:10.1177/1352458517694431
PMID:28290754
Abstract

Nocardia is a Gram-positive aerobic pathogen that usually affects immunocompromised patients. We report a case of pulmonary infection caused by a rare Nocardia species, Nocardia beijingensis, in a 50-year-old woman who had received alemtuzumab for the treatment of her multiple sclerosis. The invasive pulmonary infection was successfully treated with meropenem.

摘要

诺卡菌是一种革兰阳性需氧病原体，通常影响免疫功能低下的患者。我们报告了一例由罕见的诺卡菌属，北京诺卡菌引起的 50 岁女性肺部感染病例。该患者患有多发性硬化症，曾接受阿仑单抗治疗。侵袭性肺部感染经美罗培南治疗后成功治愈。

相似文献

1
Pulmonary Nocardia beijingensis infection associated with the use of alemtuzumab in a patient with multiple sclerosis.肺北京诺卡菌感染与多发性硬化症患者使用阿仑单抗有关。
Mult Scler. 2017 May;23(6):872-874. doi: 10.1177/1352458517694431. Epub 2017 Feb 1.
2
Nocardia beijingensis pulmonary infection successfully treated with intravenous beta-lactam antibiotics and oral minocycline.北京诺卡菌肺部感染经静脉用β-内酰胺类抗生素和口服米诺环素治疗取得成功。
J Infect Chemother. 2011 Oct;17(5):706-9. doi: 10.1007/s10156-011-0233-2. Epub 2011 Mar 17.
3
Fulminant Central Nervous System Nocardiosis in a Patient Treated With Alemtuzumab for Relapsing-Remitting Multiple Sclerosis.一名接受阿仑单抗治疗复发缓解型多发性硬化症的患者发生暴发性中枢神经系统诺卡菌病
JAMA Neurol. 2016 Jun 1;73(6):757-9. doi: 10.1001/jamaneurol.2016.0146.
4
Pancolitis a novel early complication of Alemtuzumab for MS treatment.Alemtuzumab 治疗多发性硬化症的一种新型早期并发症：全结肠炎。
Mult Scler Relat Disord. 2016 May;7:83-4. doi: 10.1016/j.msard.2016.03.014. Epub 2016 Mar 30.
5
A fatal case of pulmonary nocardiosis.一例肺诺卡菌病致死病例。
BMJ Case Rep. 2012 Feb 25;2012:bcr0920114875. doi: 10.1136/bcr.09.2011.4875.
6
Nocardia transvalensis infection in an immunocompetent patient reported from Turkey.土耳其报告的一例免疫功能正常患者的特兰斯瓦尼亚诺卡菌感染。
Tuberk Toraks. 2007;55(3):295-8.
7
Acute pneumonitis and pericarditis related to alemtuzumab therapy in relapsing-remitting multiple sclerosis.与阿仑单抗治疗复发缓解型多发性硬化症相关的急性肺炎和心包炎。
J Neurol. 2017 Jan;264(1):168-169. doi: 10.1007/s00415-016-8306-x. Epub 2016 Nov 25.
8
Parvovirus B19 infection in a patient with multiple sclerosis treated with ocrelizumab.一名接受奥瑞珠单抗治疗的多发性硬化症患者感染细小病毒B19 。
Acta Neurol Belg. 2020 Feb;120(1):231-232. doi: 10.1007/s13760-019-01227-y. Epub 2019 Oct 25.
9
Nocardia spp.: A Rare Cause of Pneumonia Globally.奴卡菌属：全球范围内一种罕见的肺炎病因。
Semin Respir Crit Care Med. 2020 Aug;41(4):538-554. doi: 10.1055/s-0040-1708816. Epub 2020 Jul 6.
10
Subcutaneous administration of alemtuzumab in patients with highly active multiple sclerosis.皮下注射阿仑单抗治疗活动期多发性硬化症。
Mult Scler. 2012 Aug;18(8):1197-9. doi: 10.1177/1352458511435716. Epub 2012 Jan 17.

引用本文的文献

1
Brain abscesses: the first report of disseminated Nocardia beijingensis infection in an immunocompetent individual in China.脑脓肿：中国首例免疫功能正常个体播散性北京诺卡菌感染报告。
BMC Neurol. 2024 Sep 13;24(1):341. doi: 10.1186/s12883-024-03826-6.
2
Metagenome next-generation sequencing plays a key role in the diagnosis and selection of effective antibiotics on the treatment of pneumonia: a case report.宏基因组下一代测序在肺炎治疗的诊断及有效抗生素选择中起关键作用：一例病例报告
Front Med (Lausanne). 2024 May 27;11:1373319. doi: 10.3389/fmed.2024.1373319. eCollection 2024.
3
Persistent infection in a patient with postoperative abscess and misuse of antibiotics in China.
中国一名术后脓肿患者的持续性感染及抗生素的不当使用。
Infect Med (Beijing). 2023 Nov 10;2(4):343-348. doi: 10.1016/j.imj.2023.11.002. eCollection 2023 Dec.
4
Autoimmune storm following alemtuzumab.阿仑单抗治疗后发生的自身免疫风暴。
BMJ Case Rep. 2022 Jun 27;15(6):e248037. doi: 10.1136/bcr-2021-248037.
5
Disseminated nocardiosis after cladribine treatment for relapsing remitting multiple sclerosis: a case report.克拉屈滨治疗复发缓解型多发性硬化后播散性诺卡菌病：一例报告
J Neurol. 2022 Aug;269(8):4557-4559. doi: 10.1007/s00415-022-11097-9. Epub 2022 Mar 30.
6
Infection in Nephrotic Syndrome Patients: Three Case Studies and A Systematic Literature Review.肾病综合征患者的感染：三个病例研究和系统文献回顾。
Front Cell Infect Microbiol. 2022 Jan 24;11:789754. doi: 10.3389/fcimb.2021.789754. eCollection 2021.
7
Efficacy and safety of alemtuzumab over 6 years: final results of the 4-year CARE-MS extension trial.阿仑单抗6年的疗效与安全性：4年CARE-MS扩展试验的最终结果
Ther Adv Neurol Disord. 2021 Apr 23;14:1756286420982134. doi: 10.1177/1756286420982134. eCollection 2021.
8
Isolated Nocardiosis, an Unrecognized Primary Immunodeficiency?孤立性奴卡菌病，一种未被认识的原发性免疫缺陷病？
Front Immunol. 2020 Oct 20;11:590239. doi: 10.3389/fimmu.2020.590239. eCollection 2020.
9
The use of alemtuzumab in patients with relapsing-remitting multiple sclerosis: the Gulf perspective.阿仑单抗在复发缓解型多发性硬化症患者中的应用：海湾地区的观点。
Ther Adv Neurol Disord. 2020 Sep 16;13:1756286420954119. doi: 10.1177/1756286420954119. eCollection 2020.
10
Infectious Complications of Biological and Small Molecule Targeted Immunomodulatory Therapies.生物制剂和小分子靶向免疫调节治疗的感染并发症。
Clin Microbiol Rev. 2020 Jun 10;33(3). doi: 10.1128/CMR.00035-19. Print 2020 Jun 17.